-
1
المؤلفون: Jannet C. Beukema, Crystal de Groot, John T.M. Plukker, Rozemarijn Vliegenthart, Johannes A. Langendijk, Peter van Luijk, Joost P. van Melle, Niek H.J. Prakken, Christina T. Muijs
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Cardiovascular Centre (CVC), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Targeted Gynaecologic Oncology (TARGON)
المصدر: Radiotherapy and Oncology, 167, 72-77. ELSEVIER IRELAND LTD
مصطلحات موضوعية: Esophageal Neoplasms, IMPACT, Esophageal cancer, Contrast Media, Gadolinium, Pilot Projects, HEART-DISEASE, CHEMORADIOTHERAPY, Radiation toxicity, Humans, Radiology, Nuclear Medicine and imaging, Prospective Studies, Survivors, RADIATION MODALITY USE, RISK, MORTALITY, Hematology, Chemoradiotherapy, Adjuvant, QUANTIFICATION, Cardiac toxicity, Fibrosis, LOW QRS VOLTAGE, Cardiotoxicity, Neoadjuvant Therapy, Cross-Sectional Studies, Oncology, ATRIAL-FIBRILLATION, Quality of Life, RADIOTHERAPY
وصف الملف: application/pdf
-
2
المؤلفون: Ina M. Jürgenliemk-Schulz, Elsbieta M. van der Steen-Banasik, Remi A. Nout, Jannet C. Beukema, Max Peters, Baukelien van Triest, Petronella O. Witteveen, Carien L. Creutzberg, Joanne A. de Hullu, Ludy C.H.W. Lutgens, Jacobus van der Velden, Henrike Westerveld, Marnix J.A. Rasing, An Snyers
المساهمون: Radiotherapy, Obstetrics and Gynaecology, CCA -Cancer Center Amsterdam, CCA - Cancer Treatment and Quality of Life, Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Gynecologic Oncology, 163(1), 117-124. Academic Press
Gynecologic oncology, 163(1), 117-124. Academic Press Inc.
Gynecologic Oncology, 163, 1, pp. 117-124
Gynecologic Oncology, 163, 117-124
Gynecologic Oncology, 163(1), 117-124. ACADEMIC PRESS INC ELSEVIER SCIENCEمصطلحات موضوعية: Adult, medicine.medical_specialty, CARCINOMA, Osteoradionecrosis, MODULATED RADIATION-THERAPY, medicine.medical_treatment, EUROPEAN-ORGANIZATION, Phases of clinical research, ORAL FLUOROPYRIMIDINE CARBAMATE, PREOPERATIVE CHEMORADIATION, Definitive chemoradiotherapy, Gastroenterology, Capecitabine, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, QUALITY-OF-LIFE, Internal medicine, medicine, Humans, Prospective Studies, Progression-free survival, Aged, Aged, 80 and over, Salvage Therapy, Chemotherapy, Toxicity, Vulvar cancer, Vulvar Neoplasms, business.industry, Obstetrics and Gynecology, Chemoradiotherapy, CHEMOTHERAPY, Middle Aged, medicine.disease, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Radiation therapy, TOXICITY CRITERIA, Oncology, Carcinoma, Squamous Cell, Locally advanced, Female, Organ-sparing, business, RADIOTHERAPY, medicine.drug
وصف الملف: application/pdf
-
3
المؤلفون: Cornelis D. de Kroon, Annerie Slot, Jannet C. Beukema, Tanja C. Stam, Judith R. Kroep, Hetty A. van den Berg, Ina M. Jürgenliemk-Schulz, Cathalijne C.B. Post, Jan Willem M. Mens, Ludy C.H.W. Lutgens, F. Koppe, Marie A.D. Haverkort, Ellen M.A. Roeloffzen, An Snyers, Carien L. Creutzberg, Eva E. Schaake, Anne M. Stiggelbout, Hans W. Nijman
المساهمون: Translational Immunology Groningen (TRIGR), Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Radiotherapy, Radiotherapie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: Gynecologic Oncology, 161(3), 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Survival, Clinician preferences, IMPACT, medicine.medical_treatment, THERAPY, VALIDATION, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Breast cancer, Quality of life, Adjuvants, Immunologic, Endometrial cancer, SDG 3 - Good Health and Well-being, QUALITY-OF-LIFE, Internal medicine, Surveys and Questionnaires, medicine, Adjuvant therapy, Humans, BREAST-CANCER, SYSTEMIC TREATMENT, Aged, Netherlands, Chemotherapy, business.industry, Obstetrics and Gynecology, Patient preferences, Chemoradiotherapy, Middle Aged, CHEMOTHERAPY, medicine.disease, Comorbidity, Combined Modality Therapy, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Endometrial Neoplasms, Adjuvant chemotherapy, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business, Adjuvant, Decision Making, Shared, Decision-making
وصف الملف: application/pdf
-
4
المؤلفون: Maaike J. Berveling, Boudewijn van Etten, Veronique E.M. Mul, Esmée A Dijkstra, Geke A. P. Hospers, Christina T. Muijs, Patrick H. J. Hemmer, Mostafa El Moumni, Jannet C. Beukema, Klaas Havenga, Gursah Kats-Ugurlu
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Robotics and image-guided minimally-invasive surgery (ROBOTICS)
المصدر: Radiotherapy and Oncology, 159, 91-97. ELSEVIER IRELAND LTD
مصطلحات موضوعية: medicine.medical_specialty, Colorectal cancer, SURGERY, medicine.medical_treatment, IORT, Brachytherapy, Rectal neoplasms, Radiation oncology, CLASSIFICATION, 030218 nuclear medicine & medical imaging, CHEMORADIOTHERAPY, POOLED ANALYSIS, 03 medical and health sciences, 0302 clinical medicine, Patient selection, RADIATION-THERAPY, Medicine, Humans, Radiology, Nuclear Medicine and imaging, Adverse effect, Neoadjuvant therapy, CONTAINING MULTIMODALITY TREATMENT, PREOPERATIVE RADIOTHERAPY, Salvage Therapy, COMPLICATIONS, RESECTION MARGIN, business.industry, Adverse effects, Medical record, Rectum, Hematology, medicine.disease, Surgery, Radiation therapy, Oncology, 030220 oncology & carcinogenesis, Resection margin, Neoplasm Recurrence, Local, business, Chemoradiotherapy
وصف الملف: application/pdf
-
5
المؤلفون: Andrés Cervantes, H.P. Knol, L. Østergaard, M.L. Lydrup, S.A. Radema, R.F. Schmitz, P. Nieboer, J. Hol, I. Edhemovic, K.C.M.J. Peeters, A. Johnsson, F.J.F. Jeurissen, Pieter J. Tanis, A.C.M. van de Luijtgaarden, P. Quarles an Ufford, H. Kim, Hein Putter, W.A. Bleeker, Tone Fokstuen, M E van Leerdam, K. Kovacs, A. Pronk, E.D. Kerver, L.G.H. Dewit, E. Garcia Granero, P.A. Nijenhuis, T. Fokstuen, S. Ottosson, P. Flygare, M.J. Safont, Iris D. Nagtegaal, F. Svendsen Jensen, C. Bratthäll, H.M. Ceha, L. Malmberg, P. Hede, W.M. van der Deure, G. Carlsson, J. Haux, Derk Jan A. de Groot, Esmée A Dijkstra, Renu R. Bahadoer, G.A.P. Nieuwenhuijzen, B. de Valk, B. Lindh, D. Hess, G.L. Beets, J.C. Bernal, A.M.E. Bruynzeel, R.M.P.H. Crolla, C. Kersten, P. Pfeiffer, S. Biondo, M.L. Silviera, Jannet C. Beukema, W.H. Schreurs, O. Hallböök, B.L. Lödén, A. Espí Macías, V. Velenik, L. Österlund, A. Slot, Geke A. P. Hospers, H. de Wilt, A.W.K.S. Marinelli, O. Lundberg, C. Radu, J. die Trill, I. Verbiené, P. Matthiessen, Mathijs P. Hendriks, J.H.M. Bekker, M. Walldén, V. Pachón, H.W. Kapiteijn, J.M. Immink, A. Piwowar, R. Salazar, L. Påhlman, P. Braam, K.E.J. Jensen, S. Festen, O. Mjåland, Elma Meershoek-Klein Kranenbarg, Jaume Capdevila, U. Palenius, K. Villmann, J.J. van der Vliet, Albert J. ten Tije, A. Berglund, Corrie A.M. Marijnen, G. Dafnis, J. Assarsson, J. Capdevila, J.W.T. Dekker, M. Grønlie Guren, G.J. Veldhuis, Q.A.J. Eijsbouts, G.J. Creemers, J.B. Tuynman, C.J.A. Punt, P.H.J.M. Veldman, J. Aparicio, Klaas Havenga, E.D. Geijsen, W.H. Steup, T. Rozema, K. Smedh, Lennart Blomqvist, J. de Boer, Cornelis J.H. van de Velde, S. Jangmalm, J.W.P. Vanstiphout, T.C. Stam, A.C.M. van den Bergh, Annet G H Roodvoets, Janet R. Vos, E.J.M. Siemerink, R.J.I. Bosker, Bengt Glimelius, A. Cervantes, E. Espin, Per Nilsson, A.J. Ten Tije, Ibrahim Edhemovic, Boudewijn van Etten, M. Tascilar, A.N. Nesbakken, G.A. Patijn, O. Reerink, Regina G. H. Beets-Tan, S. Skullman, H. Hörberg, P. Parinkh, G. Svaninger, M.B. Polée, D. Ten Bokkel Huinink, C. Hoff, A.F.T. Olieman, H. van den Berg, F.P. Peters, Torbjörn Holm, J.M. van Rooijen, M.P. Hendriks, J. Benedik, J.H. Svensson, A.L.T. Imholz
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiation Oncology, Internal medicine, VU University medical center, Ophthalmology, Amsterdam Neuroscience - Systems & Network Neuroscience, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiotherapy, Paediatric Oncology
المصدر: Lancet Oncology, 22, 29-42
Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045(20)30555-6
The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
The Lancet. Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Oncology, 22, 1, pp. 29-42
The Lancet Oncology, 22(1), 29-42. ELSEVIER
The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group
lancet oncology, 22(1), 29-42. Lancet Publishing Groupمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Population, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, Folinic acid, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], medicine, Clinical endpoint, education, education.field_of_study, Performance status, business.industry, Total mesorectal excision, Oxaliplatin, Surgery, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business, Chemoradiotherapy, medicine.drug
وصف الملف: application/pdf
-
6
المؤلفون: Tian-Tian Zhai, Johannes A. Langendijk, Peter van Luijk, Lisanne V. van Dijk, Jannet C. Beukema, Nanna M. Sijtsema, Teruki Teshima, Christina T. Muijs, Yoshifumi Kawaguchi
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)
المصدر: Radiotherapy and Oncology, 149, 222-227. ELSEVIER IRELAND LTD
مصطلحات موضوعية: medicine.medical_specialty, Lung Neoplasms, Esophageal Neoplasms, Pulmonary toxicity, Radiation Dosage, Pericardial effusion, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Radiology, Nuclear Medicine and imaging, Lung, Retrospective Studies, business.industry, Cancer, Radiotherapy Dosage, Retrospective cohort study, Hematology, medicine.disease, Radiation Pneumonitis, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cohort, Population study, Radiology, Complication, business
وصف الملف: application/pdf
-
7
المؤلفون: Hans Paul van der Laan, Joost P. van Melle, Crystal de Groot, Peter van Luijk, Niek H J Prakken, Jannet C. Beukema, Johannes A. Langendijk, Christina T. Muijs
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Cardiovascular Centre (CVC), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Targeted Gynaecologic Oncology (TARGON)
المصدر: International Journal of Radiation Oncology, Biology, Physics, 110(4), 1013-1021. ELSEVIER SCIENCE INC
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Esophageal Neoplasms, Heart disease, medicine.medical_treatment, HEART-DISEASE, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, PERFUSION, medicine, Humans, BREAST-CANCER, Radiology, Nuclear Medicine and imaging, Survivors, Radiation Injuries, RISK, DAMAGE, Radiation, medicine.diagnostic_test, CARDIAC MAGNETIC-RESONANCE, business.industry, Myocardium, Magnetic resonance imaging, Middle Aged, Esophageal cancer, medicine.disease, Fibrosis, Magnetic Resonance Imaging, Radiation therapy, CHEMORADIATION THERAPY, Regimen, Oncology, 030220 oncology & carcinogenesis, Cardiology, Female, Myocardial fibrosis, Complication, business, Perfusion, RADIOTHERAPY
وصف الملف: application/pdf
-
8
المؤلفون: Berend J van der Wilk, Hanneke W. M. van Laarhoven, Maurice J.C. van der Sangen, Janny G. Reinders, Cornelis J. A. Punt, Geke A. P. Hospers, J. Jan B. van Lanschot, Bas P. L. Wijnhoven, Ernst Jan Spillenaar Bilgen, Mark I. van Berge Henegouwen, Anna H.M. Piet, Pieter van Hagen, John T. M. Plukker, Fiebo J. W. ten Kate, Henk M.W. Verheul, Hugo W. Tilanus, Joel Shapiro, Ewout W. Steyerberg, Caroline M. van Rij, Grard A. P. Nieuwenhuijzen, Ben M Eyck, Geert-Jan Creemers, Tom Rozema, Ate van der Gaast, Reinoud J. B. Blaisse, Johannes J. Bonenkamp, Miguel A. Cuesta, Maarten C.C.M. Hulshof, Jannet C. Beukema, Olivier R. Busch
المساهمون: Radiation Oncology, Surgery, Internal medicine, CCA - Cancer Treatment and quality of life, Clinical pharmacology and pharmacy, Radiotherapy, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, Pathology, Public Health, Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 1995-2004
Journal of clinical oncology, 39(18), 1995-2004. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(18), 1995-2004. LIPPINCOTT WILLIAMS & WILKINS
Eyck, B M, van Lanschot, J J B, Hulshof, M C C M, van der Wilk, B J, Shapiro, J, van Hagen, P, Henegouwen, M I V B, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R, Creemers, G-J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van der Sangen, M J C, Rozema, T, Ten Kate, F J W, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W & van der Gaast, A 2021, ' Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 18, pp. 1995-+ . https://doi.org/10.1200/JCO.20.03614
Journal of Clinical Oncology, 39, 18, pp. 1995-2004
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-2004. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-2004. AMER SOC CLINICAL ONCOLOGYمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Standard of care, Cross trial, business.industry, Locally advanced, MEDLINE, Esophageal cancer, medicine.disease, Surgery, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Oncology, 030220 oncology & carcinogenesis, medicine, 030212 general & internal medicine, business, Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19], Chemoradiotherapy, Neoadjuvant chemoradiotherapy
وصف الملف: application/pdf
-
9
المؤلفون: Jannet C. Beukema, Shafak Aluwini, Stefan Both, W. P. Matysiak, Nanna M. Sijtsema, E. M. Gort, Charlotte L. Brouwer, Johannes A. Langendijk
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON)
المصدر: Radiotherapy and Oncology, 154, 194-200. ELSEVIER IRELAND LTD
مصطلحات موضوعية: Organs at Risk, medicine.medical_treatment, Uterine Cervical Neoplasms, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, medicine, Proton Therapy, Humans, Radiology, Nuclear Medicine and imaging, Pencil-beam scanning, Radiation treatment planning, Proton therapy, Cervical cancer, business.industry, Radiotherapy Planning, Computer-Assisted, Radiotherapy Dosage, Hematology, medicine.disease, Volumetric modulated arc therapy, Radiation therapy, Organ sparing, Oncology, 030220 oncology & carcinogenesis, Organ at risk, Female, Radiotherapy, Intensity-Modulated, business, Nuclear medicine
وصف الملف: application/pdf
-
10Electronic Resource
المؤلفون: Baukelien van Triest, Marnix Rasing, Jacobus van der Velden, Joanne A. De Hullu, Petronella O. Witteveen, Jannet C. Beukema, Elsbieta van der Steen-Banasik, Henrike Westerveld, A Snyers, Max Peters, Carien L. Creutzberg, R.A. (Remi) Nout, Ludy Lutgens, Ina Jürgenliemk-Schulz
مصطلحات الفهرس: info:eu-repo/semantics/article
-
11OC-0300 Patients’ and clinicians’ preferences in adjuvant treatment for high-risk endometrial cancer
المؤلفون: Carien L. Creutzberg, C.D. De Kroon, H. Van den Berg, F. Koppe, C. Post, L.C.H.W. Lutgens, Jannet C. Beukema, Annerie Slot, Judith R. Kroep, M. Haverkort, E. Roeloffzen, Anne M. Stiggelbout, Hans W. Nijman, An Snyers, Tanja C. Stam, Jan Willem M. Mens, E. Schaake, I.M. Jürgenliemk-Schulz
المصدر: Radiotherapy and Oncology. 161:S206-S207
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Internal medicine, Endometrial cancer, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease, Adjuvant
-
12
المساهمون: Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Targeted Gynaecologic Oncology (TARGON), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: International Journal of Radiation Oncology, Biology, Physics, 111(5). ELSEVIER SCIENCE INC
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Radiation, Oncology, business.industry, General surgery, MEDLINE, Medicine, Radiology, Nuclear Medicine and imaging, business, RADIOTHERAPY
وصف الملف: application/pdf
-
13
المؤلفون: J. Jan B. van Lanschot, Jannet C. Beukema, Herman van Dekken, Janny G. Reinders, Olivier R. Busch, Fiebo J.W. ten Kate, Bo Jan Noordman, Mathilde G. E. Verdam, Johannes J. Bonenkamp, Grard A. P. Nieuwenhuijzen, Hugo W. Tilanus, Geert-Jan Creemers, Pieter van Hagen, Mark I. van Berge Henegouwen, Tom Rozema, Mirjam A. G. Sprangers, Cornelis J. A. Punt, John T. M. Plukker, Geke A. P. Hospers, Ate van der Gaast, Reinoud J. B. Blaisse, Maarten C.C.M. Hulshof, Bas P. L. Wijnhoven, Katharina Biermann, Anna H.M. Piet, Henk M.W. Verheul, Hanneke W. M. van Laarhoven, Ernst Jan Spillenaar Bilgen, Ewout W. Steyerberg, Miguel A. Cuesta, Maurice J.C. van der Sangen, Sjoerd M. Lagarde, Caroline M. van Rij
المساهمون: Surgery, Pathology, Radiotherapy, Public Health, Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), APH - Mental Health, CCA - Cancer Treatment and Quality of Life, APH - Personalized Medicine, Medical Psychology, Graduate School, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, APH - Aging & Later Life, APH - Methodology, CCA - Cancer Treatment and quality of life, Medical oncology, Radiation Oncology, Clinical pharmacology and pharmacy, Amsterdam Gastroenterology Endocrinology Metabolism
المصدر: Journal of Clinical Oncology, 36, 3, pp. 268-275
Noordman, B J, Verdam, M G E, Lagarde, S M, Hulshof, M C C M, van Hagen, P, van Berge Henegouwen, M I, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R, Ten Kate, F J W, Creemers, G-J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Spillenaar Bilgen, E J, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W, van der Gaast, A, Sprangers, M A G & van Lanschot, J J B 2018, ' Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer : Results From the Randomized CROSS Trial ', Journal of Clinical Oncology, vol. 36, no. 3, pp. 268-275 . https://doi.org/10.1200/JCO.2017.73.7718
Journal of Clinical Oncology, 36(3), 268-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36(3), 268-279. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 36(3), 268-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 268-275
Journal of Clinical Oncology, 36(3), 268-275. American Society of Clinical Oncology
JOURNAL OF CLINICAL ONCOLOGY
JOURNAL OF CLINICAL ONCOLOGY, 36(3), 268-275مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, CARCINOMA, SURGERY, medicine.medical_treatment, 030230 surgery, Gastroenterology, THERAPY, law.invention, 03 medical and health sciences, chemistry.chemical_compound, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], CHEMORADIATION, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, Quality of life, Randomized controlled trial, SDG 3 - Good Health and Well-being, law, Internal medicine, Medicine, EXTENDED TRANSTHORACIC RESECTION, business.industry, PERIOPERATIVE CHEMOTHERAPY, LONG-TERM SURVIVORS, Cancer, PHASE-III TRIAL, ADENOCARCINOMA, Esophageal cancer, medicine.disease, Carboplatin, humanities, Surgery, Radiation therapy, Oncology, chemistry, Esophagectomy, 030220 oncology & carcinogenesis, business, Chemoradiotherapy, CLINICAL-TRIALS
وصف الملف: application/pdf
-
14
المؤلفون: Johannes A. Langendijk, Jannet C. Beukema, Stefan Both, Charlotte L. Brouwer, W. P. Matysiak, E. M. Gort, M. J. Spijkerman-Bergsma, M. De Groot
المصدر: Radiotherapy and Oncology. 152:S892-S893
مصطلحات موضوعية: Cervical cancer, Oncology, medicine.medical_specialty, business.industry, Internal medicine, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease, Proton therapy
-
15
المؤلفون: Geke A. P. Hospers, Daan Nieboer, Bas P. L. Wijnhoven, Anna H.M. Piet, Berend J van der Wilk, Katharina Biermann, Joel Shapiro, Mark I. van Berge Henegouwen, Ben M Eyck, Henk M.W. Verheul, Hanneke W. M. van Laarhoven, Maarten C.C.M. Hulshof, Olivier R. Busch, Janny G. Reinders, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Caroline M. van Rij, Pieter van Hagen, Ate van der Gaast, Fiebo J. W. ten Kate, Johannes J. Bonenkamp, Miguel A. Cuesta, Ernst Jan Spillenaar Bilgen, Geert-Jan Creemers, Tom Rozema, Reinoud J. B. Blaisse, Jannet C. Beukema, Cornelis J. A. Punt, Herman van Dekken, Hugo W. Tilanus, J. Jan B. van Lanschot, John T. M. Plukker
المصدر: Diseases of the Esophagus. 32
مصطلحات موضوعية: medicine.medical_specialty, business.industry, 10 year follow up, Gastroenterology, Cancer, General Medicine, medicine.disease, Surgery, law.invention, Randomized controlled trial, law, Medicine, business, Neoadjuvant chemoradiotherapy
-
16
المؤلفون: Cornelis J. A. Punt, H.J.T. Rutten, Jannet C. Beukema, M.J.T. van der Sangen, Jeroen Buijsen, G. Paardekooper, E.M. Hendriksen, Eva Versteijne, Mustafa Suker, Tom Rozema, K.B.C. Groothuis, Aeilko H. Zwinderman, G. van Tienhoven, C.H.J. van Eijck, A. Bruynzeel, Karen J. Neelis, Joost J. Nuyttens, Martijn Intven
المصدر: International Journal of Radiation Oncology-Biology-Physics, 102(5), 1606-1607
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Preoperative chemoradiotherapy, Radiation, business.industry, medicine.disease, Outcome (game theory), 03 medical and health sciences, 0302 clinical medicine, Borderline resectable, 030220 oncology & carcinogenesis, Pancreatic cancer, Internal medicine, Medicine, 030211 gastroenterology & hepatology, Radiology, Nuclear Medicine and imaging, business
-
17
المؤلفون: Jannet C. Beukema, Johannes A. Langendijk, W. P. Matysiak, M. J. Spijkerman-Bergsma, Stefan Both, Charlotte L. Brouwer, E. M. Gort
المصدر: Radiotherapy and Oncology. 133:S155-S156
مصطلحات موضوعية: Cervical cancer, medicine.medical_specialty, Organ sparing, Oncology, business.industry, medicine, Robustness (evolution), Radiology, Nuclear Medicine and imaging, Hematology, Radiology, medicine.disease, business
-
18
المؤلفون: Johannes J. Bonenkamp, Maurice J.C. van der Sangen, Herman van Dekken, Grard A. P. Nieuwenhuijzen, Pieter van Hagen, Ernst Jan Spillenaar Bilgen, Hugo W. Tilanus, Ate van der Gaast, Caroline M. van Rij, Geke A. P. Hospers, Olivier R. Busch, Maarten C.C.M. Hulshof, Miguel A. Cuesta, Reinoud J. B. Blaisse, Bas P. L. Wijnhoven, Joel Shapiro, Anna H.M. Piet, Katharina Biermann, Fiebo J. W. ten Kate, Henk M.W. Verheul, Janny G. Reinders, Hanneke W. M. van Laarhoven, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, John T. M. Plukker, Jannet C. Beukema, Geert-Jan Creemers, Tom Rozema, Cornelis J. A. Punt
المساهمون: CCA -Cancer Center Amsterdam, Radiotherapy, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, Oncology, Other departments, Pathology, Public Health, Medical Oncology, Medical oncology, Radiation Oncology, CCA - Innovative therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)
المصدر: lancet oncology, 16(9), 1090-1098. Lancet Publishing Group
Lancet Oncology, 16, 9, pp. 1090-8
Lancet Oncology, 16(9), 1090-1098. Lancet Publishing Group
Lancet Oncology, 16, 1090-8
Shapiro, J, van Lanschot, J J B, Hulshof, M C C M, van Hagen, P, Henegouwen, M I V, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R C, Ten Kate, F J W, Creemers, G J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W & van der Gaast, A 2015, ' Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial ', Lancet Oncology, vol. 16, no. 9, pp. 1090-1098 . https://doi.org/10.1016/S1470-2045(15)00040-6
Lancet Oncology, 16(9), 1090-1098. ELSEVIER SCIENCE INCمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Esophageal Neoplasms, Paclitaxel, CARCINOMA, medicine.medical_treatment, Kaplan-Meier Estimate, Disease-Free Survival, Carboplatin, DEFINITIONS, chemistry.chemical_compound, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], Breast cancer, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, END-POINTS, Carcinoma, medicine, Clinical endpoint, Humans, BREAST-CANCER, METAANALYSIS, Cancer staging, Aged, Neoplasm Staging, business.industry, PERIOPERATIVE CHEMOTHERAPY, PHASE-III TRIAL, ADENOCARCINOMA, Chemoradiotherapy, Middle Aged, medicine.disease, Surgery, Radiation therapy, Regimen, Oncology, chemistry, TESTS, SURVIVAL, Female, Esophagogastric Junction, Fluorouracil, business, Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]
-
19
المؤلفون: Karin Tamas, Tonnis H. van Dijk, Urszula M. Domanska, Hetty Timmer-Bosscha, Klaas Havenga, Arend Karrenbeld, Wilfred F.A. den Dunnen, Wim J. Sluiter, Wouter B. Nagengast, Jannet C. Beukema, Marcel A.T.M. van Vugt, Elisabeth G.E. de Vries, Annemiek M.E. Walenkamp, Geke A.P. Hospers
المصدر: Current Angiogenesis. 3:164-173
مصطلحات موضوعية: Cancer Research, Oncology
-
20
المؤلفون: Geke A. P. Hospers, Tonnis H. van Dijk, Elisabeth G.E. de Vries, Klaas Havenga, Arend Karrenbeld, Wim J. Sluiter, Urszula Domańska, Jannet C. Beukema, Hetty Timmer-Bosscha, Marcel A. T. M. van Vugt, K. Tamas, Annemiek M E Walenkamp
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), Damage and Repair in Cancer Development and Cancer Treatment (DARE)
المصدر: Current Pharmaceutical Design, 21(17), 2276-2283. BENTHAM SCIENCE PUBL LTD
مصطلحات موضوعية: Male, Oncology, Colorectal cancer, medicine.medical_treatment, CHEMOKINE RECEPTOR CXCR4, chemotherapy, THERAPY, Metastasis, Antineoplastic Combined Chemotherapy Protocols, Drug Discovery, chemokine ligand 12 (CXCL12), OXALIPLATIN, COLON-CANCER, Middle Aged, Immunohistochemistry, Primary tumor, Neoadjuvant Therapy, embryonic structures, Female, biological phenomena, cell phenomena, and immunity, medicine.drug, Chemokine receptor 4 (CXCR4), Adult, (metastatic) rectal cancer, Receptors, CXCR4, medicine.medical_specialty, Bevacizumab, BEVACIZUMAB, LEUCOVORIN, Capecitabine, Internal medicine, medicine, Humans, radiotherapy, Aged, Neoplasm Staging, Pharmacology, Chemotherapy, Rectal Neoplasms, business.industry, medicine.disease, PHASE-III, Chemokine CXCL12, biological factors, FLUOROURACIL, Oxaliplatin, Radiation therapy, METASTATIC COLORECTAL-CANCER, business, PREOPERATIVE CHEMORADIOTHERAPY